Sclerostin resistance improves glucose metabolism and protects bone mass in a mouse model of type 1 diabetes

被引：0
|
作者：
Leanza, G. [1 ]
Fontana, F. [2 ]
Alippe, Y. [2 ]
Lee, S. -Y. [2 ]
Strollo, R. [1 ]
Pozzilli, P. [1 ]
Remedi, M. [3 ]
Civitelli, R. [2 ]
Napoli, N. [1 ]
机构：
[1] Campus Biomed Univ Rome, Dept Med, Unit Endocrinol & Diabet, Rome, Italy
[2] Washington Univ, Dept Med Bone & Mineral Dis, St Louis, MO 63110 USA
[3] Washington Univ, Dept Med, Div Endocrinol, Metab & Lipid Ctr, St Louis, MO USA
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
559
引用
收藏
页码：S270 / S270
页数：1
相关论文
共 50 条
  • [1] Type 1 Diabetes: Sclerostin Resistance Improves Glucose Metabolism and Protects Bone Mass
    Leanza, Giulia
    Alippe, Yael
    Lee, Seung-Yon
    Strollo, Rocky
    Pozzilli, Paolo
    Civitelli, Roberto
    Napoli, Nicola
    DIABETES, 2019, 68
  • [2] Sclerostin Resistance Protects Bone Mass and Improves Insulin Sensitivity in a Mouse Model of Type 1 Diabetes
    Leanza, Giulia
    Fontana, Francesca
    Strollo, Rocky
    Pozzilli, Paolo
    Napoli, Nicola
    Civitelli, Roberto
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 41 - 41
  • [3] Sclerostin Resistance Protects Bone Mass and Retards the Onset of Metabolic Abnormalities in a Mouse Model of Type 1 Diabetes
    Leanza, Giulia
    Strollo, Rocky
    Pozzilli, Paolo
    Civitelli, Roberto
    Napoli, Nicola
    DIABETES, 2018, 67
  • [4] Resistance to Lrp5 Inhibitors Protects Bone Mass and Improves Glucose Metabolism in Type 1 Diabetes
    Leanza, Giulia
    Fontana, Francesca
    Alippe, Yael
    Lee, Seung-Yon
    Remedi, Maria
    Napoli, Nicola
    Civitelli, Roberto
    Strollo, Rocky
    Pozzilli, Paolo
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 19 - 19
  • [5] Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus
    Hamann, Christine
    Rauner, Martina
    Hoehna, Yvonne
    Bernhardt, Ricardo
    Mettelsiefen, Jan
    Goettsch, Claudia
    Guenther, Klaus-Peter
    Stolina, Marina
    Han, Chun-Ya
    Asuncion, Franklin J.
    Ominsky, Michael S.
    Hofbauer, Lorenz C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (03) : 627 - 638
  • [6] Association of Sclerostin with Bone Metabolism, Bone Mineral Density, and Oxidative Stress in Adults with Type 1 Diabetes Mellitus
    Soysal-Atile, Neslihan
    Bilir, Bulent
    Ugur-Altun, Betul
    Ekiz-Bilir, Betul
    Celik, Huseyin
    DIABETES, 2016, 65 : A167 - A167
  • [7] Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density
    Tsentidis, Charalampos
    Gourgiotis, Dimitrios
    Kossiva, Lydia
    Marmarinos, Antonios
    Doulgeraki, Artemis
    Karavanaki, Kyriaki
    PEDIATRIC DIABETES, 2016, 17 (04) : 289 - 299
  • [8] Atorvastatin improves glucose metabolism and reverses the diabetic state in a non-genetic mouse model of type 2 diabetes
    Machado, U. F.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S359 - S359
  • [9] ROLE OF SERUM SCLEROSTIN ON BONE METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Garcia-Martin, Antonia
    Reyes-Garcia, Rebeca
    Rozas-Moreno, Pedro
    Morales-Santana, Sonia
    Garcia-Fontana, Beatriz
    Munoz-Torres, Manuel
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S150 - S151
  • [10] Sclerostin and insulin resistance in prediabetes. Evidence of a crosstalk between bone and glucose metabolism
    Daniele, G.
    Winnier, D.
    Mari, A.
    Bruder, J.
    Fourcaudot, M.
    Pengou, Z.
    Tripathy, D.
    Jenkinson, C.
    Folli, F.
    DIABETOLOGIA, 2015, 58 : S298 - S298
12345